v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,391 $ 3,240
Accounts receivable 0 1,000
Prepaid expenses 112 384
Other current assets 11 11
Total current assets 1,514 4,635
Property, Plant and Equipment, Net 66 0
Other investment 5,350 5,350
Total assets 6,930 9,985
Current liabilities:    
Accounts payable 1,597 508
Accrued research and development costs 26 198
Accrued expenses and other current liabilities 220 194
Total current liabilities 1,843 900
Commitments and contingencies (Note 6) 0 0
Stockholders' equity    
Preferred stock, no par value, 100,000,000 shares authorized and 351,037 shares of Series A convertible preferred stock issued and outstanding at June 30, 2026 and December 31, 2025 0 0
Common stock, no par value, 400,000,000 shares authorized at June 30, 2026 and December 31, 2025; 4,330,314 and 3,925,314 shares issued at June 30, 2026 and December 31, 2025, respectively; 4,256,284 and 3,821,236 shares outstanding at June 30, 2026 and December 31, 2025, respectively 0 0
Paid-in capital 281,039 280,105
Accumulated deficit (275,952) (271,020)
Total stockholders' equity 5,087 9,085
Total liabilities and stockholders' equity $ 6,930 $ 9,985